bromocriptine has been researched along with furosemide in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (43.75) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 5 (31.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Al-Dujaili, EA; Besser, GM; Edwards, CR; Hanker, JP; Miall, PA; Thorner, MO | 1 |
Higuchi, M; Kolloch, R; Krück, F; Stumpe, KO; Vetter, H | 1 |
Madon, RJ; Shennan, DB | 1 |
Bol'shakova, TD; Gitel', EP; Lukovnikova, LP; Podzolkov, VI; Ziabreva, EV | 1 |
Beck, FW; Sowers, JR | 1 |
Marchesini, G; Pisi, E | 1 |
Althoff, PH; Fassbinder, W; Jungmann, E; Magnet, W; Rosak, C; Schöffling, K | 1 |
Berg, G; Martin, VI; Sowers, JR; Stern, N | 1 |
Ajduk, J; Košec, A; Kruljac, I | 1 |
1 review(s) available for bromocriptine and furosemide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for bromocriptine and furosemide
Article | Year |
---|---|
Inhibition of the plasma-aldosterone response to frusemide by bromocriptine.
Topics: Aldosterone; Bromocriptine; Dopamine; Ergolines; Furosemide; Humans; Injections, Intravenous; Mineralocorticoid Receptor Antagonists; Potassium; Renin; Sodium | 1975 |
14 other study(ies) available for bromocriptine and furosemide
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
[Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)].
Topics: Adult; Blood Pressure; Bromocriptine; Furosemide; Humans; Hypertension; Hypothalamus; Male; Natriuresis; Prolactin; Renin | 1977 |
An effect of prolactin on K uptake by lactating rat mammary tissue.
Topics: Animals; Bromocriptine; Carrier Proteins; Female; Furosemide; Lactation; Mammary Glands, Animal; Ouabain; Potassium; Prolactin; Rats; Sodium-Potassium-Chloride Symporters | 1991 |
[Role of prolactin in disorders of water and salt metabolism in patients with hypertension].
Topics: Adolescent; Adult; Bromocriptine; Circadian Rhythm; Furosemide; Humans; Hyperprolactinemia; Hypertension; Male; Natriuresis; Potassium; Water-Electrolyte Imbalance | 1986 |
Role of dopamine in the regulation of aldosterone and 18-hydroxycorticosterone secretion in man.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Bromocriptine; Corticosterone; Dopamine; Electrolytes; Furosemide; Humans; Hydrocortisone; Isometric Contraction; Male; Posture | 1984 |
[Hepatic coma. Therapeutic aspects].
Topics: Amino Acids; Bromocriptine; Electrolytes; Furosemide; Glucose; Hepatic Encephalopathy; Histamine H2 Antagonists; Humans; Infusions, Parenteral; Levodopa; Nitrogen; Spironolactone; Vitamin B Complex | 1984 |
[Abnormal behavior of aldosterone in patients with diabetes mellitus].
Topics: Adult; Aldosterone; Bromocriptine; Diabetes Mellitus; Female; Furosemide; Humans; Male; Middle Aged | 1983 |
Dopaminergic control of 18-hydroxycorticosterone responses to posture, isometric exercise, and diuretic administration in normal man.
Topics: 18-Hydroxycorticosterone; Adult; Aldosterone; Bromocriptine; Corticosterone; Epinephrine; Furosemide; Humans; Isometric Contraction; Male; Norepinephrine; Physical Exertion; Posture; Prolactin | 1982 |
Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
Topics: Adult; Audiometry, Pure-Tone; Bromocriptine; Cochlear Diseases; Diuretics; Furosemide; Glucocorticoids; Hearing Loss, Sensorineural; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Pituitary Neoplasms; Prolactinoma; Recurrence | 2019 |